Remdesivir for severe covid-19: a clinical practice guideline

Rochwerg, Bram; Agarwal, Arnav; Zeng, Linan; Leo, Yee-Sin; Appiah, John Adabie; Agoritsas, Thomas; Bartoszko, Jessica; Brignardello-Petersen, Romina; Ergan, Begum; Ge, Long; Geduld, Heike; Gershengorn, Hayley B; Manai, Hela; Huang, Minhua; Lamontagne, François; Kanda, Seema; Kawano-Dourado, Leticia; Kurian, Linda; Kwizera, Arthur; Murthy, Srinivas; Qadir, Nida; Siemieniuk, Reed; Silvestre, Maria Asuncion; Vandvik, Per Olav; Ye, Zhikang; Zeraatkar, Dena; Guyatt, Gordon

doi:10.1136/bmj.m2924

Scientific article

English

Remdesivir for severe covid-19: a clinical practice guideline

Published inBMJ (Clinical Research Edition), vol. 370, m2924

Publication date2020

Abstract

What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.

Keywords

Adenosine Monophosphate/analogs & derivatives/therapeutic use
Alanine/analogs & derivatives/therapeutic use
Antiviral Agents/therapeutic use
Betacoronavirus/isolation & purification
Coronavirus Infections/diagnosis/drug therapy/mortality/therapy/virology
Guideline Adherence
Humans
Length of Stay/statistics & numerical data
Network Meta-Analysis
Pandemics
Pneumonia, Viral/diagnosis/mortality/therapy/virology
Randomized Controlled Trials as Topic
Respiration, Artificial/statistics & numerical data
Severity of Illness Index
Time Factors
Treatment Outcome

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Groupe Perrier Arnaud (Médecine interne générale, de réhabilitation et de gériatrie) (585)

Citation (ISO format)

ROCHWERG, Bram et al. Remdesivir for severe covid-19: a clinical practice guideline. In: BMJ (Clinical Research Edition), 2020, vol. 370, p. m2924. doi: 10.1136/bmj.m2924

Article (Published version)

CC BY-NC

Identifiers

PID : unige:141560
DOI : 10.1136/bmj.m2924
PMID : 32732352

Additional URL for this publicationhttps://www.bmj.com/content/370/bmj.m2924

Journal ISSN0959-8138

379views

468downloads

Creation23/08/2020 18:20:00

First validation23/08/2020 18:20:00

Update15/03/2023 22:35:12

Status update15/03/2023 22:35:10

Last indexation14/03/2025 17:07:05

Archive ouverte UNIGE

Remdesivir for severe covid-19: a clinical practice guideline

What is the role of remdesivir in the treatment of severe covid-19? This guideline was triggered by the ACTT-1 trial published in the New England Journal of Medicine on 22 May 2020.

Technical informations